Actively Recruiting
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
Led by Shanghai Chest Hospital · Updated on 2025-05-28
216
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study focuses on the significant impact of lung cancer in China, highlighted by its high incidence and mortality rates, influenced by factors like aging populations, smoking, and environmental issues. It emphasizes the importance of understanding the duration, severity, and factors affecting post-surgery symptoms like pain and coughing in patients. The research underlines the value of patient-reported outcomes (PROs) in enhancing postoperative care and survival rates through improved symptom monitoring and patient engagement. Utilizing internet technology, specifically a platform integrated with WeChat, the study aims to improve patient management and follow-ups post-discharge. The objective is to use mobile internet technology to build a high-quality prospective database on postoperative lung cancer patient outcomes, analyzing factors affecting postoperative discomfort and assessing the role of interactive platforms in improving patient care.
CONDITIONS
Official Title
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Stage I-III lung cancer and surgically treated at the study center
- Owns and uses a smartphone and can use WeChat
- Volunteers to participate and signs an informed consent form
You will not qualify if you...
- Received any non-surgical anti-tumor therapy (radiotherapy, chemotherapy, targeted therapy, or immunotherapy) for lung cancer during follow-up
- Developed serious health issues after enrollment that prevent surgery or anesthesia
- Condition changed after admission requiring emergency surgery instead of planned elective surgery
- Voluntarily withdraws or stops treatment at any time during the study due to personal reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zuodong Song
Shanghai, Shanghai Municipality, China, 200030
Actively Recruiting
Research Team
X
Xinghua Cheng, MD
CONTACT
X
Xinghua Cheng
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here